Myriad Genetics (MYGN) EBITDA Margin (2009 - 2026)
Myriad Genetics (MYGN) reported EBITDA Margin of 15.32% for Q1 2026, down 52.0% year-over-year from 31.92% in Q1 2025, and down 463.86% quarter-over-quarter from 2.72% in Q4 2025.
Myriad Genetics (MYGN) EBITDA Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of EBITDA Margin data on file, last reported at 15.32% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 15.32%, down 52.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 46.91% (down 3194.0% YoY), and the FY2025 annual result was 46.96%, down 3222.0% from the prior year.
- EBITDA Margin retreated to 15.32% in Q1 2026 per MYGN's latest filing, from 2.72% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2.72% in Q4 2025 and troughed at 154.48% in Q2 2025.
- A 5-year average of 28.19% and a median of 15.97% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin surged 4470 bps in 2024, then plunged 13722 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 29.36% in 2022, then jumped by 46 bps to 15.97% in 2023, then decreased by 16 bps to 18.52% in 2024, then jumped by 85 bps to 2.72% in 2025, then tumbled by 464 bps to 15.32% in 2026.
- Business Quant data shows MYGN's EBITDA Margin at 15.32% in Q1 2026, 2.72% in Q4 2025, and 11.33% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.21% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 19.42% |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -15.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.32% |
| Dec 31, 2025 | -2.72% |
| Sep 30, 2025 | -11.33% |
| Jun 30, 2025 | -154.48% |
| Mar 31, 2025 | -14.80% |
| Dec 31, 2024 | -18.52% |
| Sep 30, 2024 | -9.38% |
| Jun 30, 2024 | -17.26% |
| Mar 31, 2024 | -13.80% |
| Dec 31, 2023 | -15.97% |
| Sep 30, 2023 | -31.32% |
| Jun 30, 2023 | -61.96% |
| Mar 31, 2023 | -28.81% |
| Dec 31, 2022 | -29.36% |
| Sep 30, 2022 | -28.77% |
| Jun 30, 2022 | -9.93% |
| Mar 31, 2022 | -15.52% |
| Dec 31, 2021 | -26.80% |
| Sep 30, 2021 | -47.76% |
| Jun 30, 2021 | -10.98% |